Dr Peter Gill

Honorary Associate
Medicine, Sydney Medical School
NHMRC Clinical Trials Centre

Telephone (08) 8222-4154
Fax (08) 8222 5896

Map

Selected grants

2013

  • SNAC1: A randomised trial of sentinel node based management versus axillary clearance for women with small breast cancers; Gill P, Wetzig N, Ung O, Campbell I, Hague W, Farshid G; National Health and Medical Research Council (NHMRC)/Project Grants.

2008

  • SNAC1: A randomised trial of sentinel node based management versus axillary clearance for women with small unifocal breast cancers; Collins J, Gill P, Wetzig N, Ung O, Bilous M, Campbell I, Collins J; National Health and Medical Research Council (NHMRC)/Project Grants.
  • SNAC-2: A randomised trial of extending sentinel node based management to women with larger or multifocal breast cancers; Wetzig N, Collins J, Campbell I, Gill P, Ung O, Collins J, Bilous M; National Health and Medical Research Council (NHMRC)/Project Grants.

2007

  • Snac 1: A randomised trial on sentinel node based management versus axillary clearance for women with small breast cancers; Gill P, Wetzig N, Gebski V, Ung O, Campbell I, Oliver D; National Health and Medical Research Council (NHMRC)/Project Grants.
  • SNAC2: A randomised trial of extending sentinal node based management to women with larger or multifocal breast cancers; Ung O, Gill G, Collins J, Wetzig N, Gill P, Campbell I, Collins J, Oliver D; Cancer Council New South Wales/Research Project Grants.

2003

  • Sentinel node biopsy versus axillary clearance in early breast cancer: the SNAC Trial?; Gill P, Collins J, Wetzig N, Collins J, Ung O, Stockler M; National Health and Medical Research Council (NHMRC)/Clinical Trial Large Scale (CTLS).

2002

  • Sentinal node biopsy versus axillary clearance in ealy breast cancer: the SNAC trial; Gill P; National Breast Cancer Foundation/Research Grant.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Garcia-Closas, M., Couch, F., Lindstrom, S., Michailidou, K., Schmidt, M., Brook, M., Orr, N., Rhie, S., Riboli, E., Feigelson, H., Carpenter, J., Balleine, R., et al (2013). Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature Genetics, 45(4), 392-398. [More Information]
  • Tewari, N., Gill, P., Bochner, M., Kollias, J. (2008). Comparison of Volume Displacement Versus Circumferential Arm Measurements for Lymphoedema: Implications for the SNAC Trial. ANZ Journal of Surgery, 78(10), 889-893. [More Information]
  • Smith, M., Gill, P., Wetzig, N., Sourjina, T., Simes, R., Stockler, M. (2007). Bs06 patient-rated outcome measures were more sensitive than clinician-rated measures at distinguishing the effects of sentinel node biopsy and axillary clearance in the snac trial. ANZ Journal of Surgery, 77(Suppl. 1), A2-A2. [More Information]
  • Gill, P., Gebski, V., Wetzig, N., Ung, O., Campbell, I., Collins, J., Sourjina, T., Coskinas, X., Stockler, M., Simes, R. (2006). Sentinel node (SN) based management causes less arm swelling and better quality of life than routine axillary clearance (AC): 1 year outcomes of the SNAC trial. Breast Cancer Research and Treatment, 100(Supplement 1), S14-S14.
  • Wetzig, N., Gill, P., Ung, O., Collins, J., Kollias, J., Gillett, D., Gebski, V., Greig, C., Ray, A., Stockler, M. (2005). Participation in the RACS sentinel node biopsy versus axillary clearance trial. ANZ Journal of Surgery, 75(3), 98-100. [More Information]

Conferences

  • Wetzig, N., Gill, P., Ung, O., Collins, J., Kollias, J., Gillette, D., Gebski, V., Greig, C., Ray, A., Stockler, M. (2002). Eligibility and Choice in the royal Australiasian College of Surgeons "SNAC Trial" of Sentinel Node Biopsy versus axillary clearance in operable breast cancer. 3rd International Sentinel Node Congress.

2013

  • Garcia-Closas, M., Couch, F., Lindstrom, S., Michailidou, K., Schmidt, M., Brook, M., Orr, N., Rhie, S., Riboli, E., Feigelson, H., Carpenter, J., Balleine, R., et al (2013). Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature Genetics, 45(4), 392-398. [More Information]

2008

  • Tewari, N., Gill, P., Bochner, M., Kollias, J. (2008). Comparison of Volume Displacement Versus Circumferential Arm Measurements for Lymphoedema: Implications for the SNAC Trial. ANZ Journal of Surgery, 78(10), 889-893. [More Information]

2007

  • Smith, M., Gill, P., Wetzig, N., Sourjina, T., Simes, R., Stockler, M. (2007). Bs06 patient-rated outcome measures were more sensitive than clinician-rated measures at distinguishing the effects of sentinel node biopsy and axillary clearance in the snac trial. ANZ Journal of Surgery, 77(Suppl. 1), A2-A2. [More Information]

2006

  • Gill, P., Gebski, V., Wetzig, N., Ung, O., Campbell, I., Collins, J., Sourjina, T., Coskinas, X., Stockler, M., Simes, R. (2006). Sentinel node (SN) based management causes less arm swelling and better quality of life than routine axillary clearance (AC): 1 year outcomes of the SNAC trial. Breast Cancer Research and Treatment, 100(Supplement 1), S14-S14.

2005

  • Wetzig, N., Gill, P., Ung, O., Collins, J., Kollias, J., Gillett, D., Gebski, V., Greig, C., Ray, A., Stockler, M. (2005). Participation in the RACS sentinel node biopsy versus axillary clearance trial. ANZ Journal of Surgery, 75(3), 98-100. [More Information]

2002

  • Wetzig, N., Gill, P., Ung, O., Collins, J., Kollias, J., Gillette, D., Gebski, V., Greig, C., Ray, A., Stockler, M. (2002). Eligibility and Choice in the royal Australiasian College of Surgeons "SNAC Trial" of Sentinel Node Biopsy versus axillary clearance in operable breast cancer. 3rd International Sentinel Node Congress.

To update your profile click here. For support on your academic profile contact .